Literature DB >> 18305557

ETV6 mutations and loss in AML-M0.

F P G Silva, B Morolli, C T Storlazzi, A Zagaria, L Impera, B Klein, H Vrieling, H C Kluin-Nelemans, M Giphart-Gassler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18305557     DOI： 10.1038/leu.2008.34

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Clinical effect of point mutations in myelodysplastic syndromes.

Authors:  Rafael Bejar; Kristen Stevenson; Omar Abdel-Wahab; Naomi Galili; Björn Nilsson; Guillermo Garcia-Manero; Hagop Kantarjian; Azra Raza; Ross L Levine; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

2.  CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.

Authors:  Claudia Haferlach; Ulrike Bacher; Alexander Kohlmann; Sonja Schindela; Tamara Alpermann; Wolfgang Kern; Susanne Schnittger; Torsten Haferlach
Journal:  Haematologica       Date:  2011-03-21       Impact factor: 9.941

Review 3.  Germline ETV6 mutations and predisposition to hematological malignancies.

Authors:  Simone Feurstein; Lucy A Godley
Journal:  Int J Hematol       Date:  2017-05-29       Impact factor: 2.490

4.  Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.

Authors:  Fernando P G Silva; Inês Almeida; Bruno Morolli; Geeske Brouwer-Mandema; Hans Wessels; Rolf Vossen; Harry Vrieling; Erik W A Marijt; Peter J M Valk; Hanneke C Kluin-Nelemans; Wolfgang R Sperr; Wolf-Dieter Ludwig; Micheline Giphart-Gassler
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

5.  SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature.

Authors:  Amy M Becker; Kathryn H Dao; Bobby Kwanghoon Han; Roger Kornu; Shuchi Lakhanpal; Angela B Mobley; Quan-Zhen Li; Yun Lian; Tianfu Wu; Andreas M Reimold; Nancy J Olsen; David R Karp; Fatema Z Chowdhury; J David Farrar; Anne B Satterthwaite; Chandra Mohan; Peter E Lipsky; Edward K Wakeland; Laurie S Davis
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.

Authors:  Feng-Ming Tien; Hsin-An Hou; Cheng-Hong Tsai; Jih-Luh Tang; Yu-Chiao Chiu; Chien-Yuan Chen; Yuan-Yeh Kuo; Mei-Hsuan Tseng; Yen-Ling Peng; Ming-Chih Liu; Chia-Wen Liu; Xiu-Wen Liao; Liang-In Lin; Chien-Ting Lin; Shang-Ju Wu; Bor-Sheng Ko; Szu-Chun Hsu; Shang-Yi Huang; Ming Yao; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Blood Cancer J       Date:  2018-08-31       Impact factor: 11.037

7.  t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.

Authors:  Sarah B Mueller; Paola Dal Cin; Long P Le; Dora Dias-Santagata; Jochen K Lennerz; A John Iafrate; Hetal Desai Marble; Andrew M Brunner; Matthew J Weinstock; Marlise R Luskin; Daniel J De Angelo; Richard M Stone; Valentina Nardi
Journal:  Blood Adv       Date:  2022-01-08

8.  Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.

Authors:  Simone Feurstein; Frank G Rücker; Lars Bullinger; Winfried Hofmann; Georgi Manukjan; Gudrun Göhring; Ulrich Lehmann; Michael Heuser; Arnold Ganser; Konstanze Döhner; Brigitte Schlegelberger; Doris Steinemann
Journal:  BMC Genomics       Date:  2014-09-11       Impact factor: 3.969
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.